Board meetings, strategic plans, and buyer signals from Darlene G. Zangara’s organization
Jun 10, 2026·BoardMeeting
Board
Health Services Advisory Council Minutes
The council received an update regarding the implementation of medical frailty definitions for H.R. 1 community engagement requirements, noting CMS's narrow interpretation. A significant portion of the meeting was dedicated to the Minnesota Health Care Programs (MHCP) coverage policy for enclosed beds used by members with complex behavioral or medical needs. The discussion covered clinical evidence, coverage criteria, technology hubs, and the necessity of behavioral interventions. The council made formal recommendations to require separate criteria for behavioral and medical diagnoses, to implement a joint review process for authorizations, to require concurrent behavioral therapy, and to authorize coverage for the technology hub.
Enterprise
Get verified public-sector contacts at scale
Find verified emails, direct dials, role context, job-change updates, and organization signals across every public-sector account you sell to.
Behavioral Health Planning Council Meeting Minutes
The council meeting addressed several key topics including an update on the revalidation process for high-risk Medicaid providers and an overview of federal requirements concerning the Mental Health Block Grant. Members reviewed the upcoming application process for the Federal Fiscal Year 2027 block grants and received a comprehensive presentation on the State Opioid Response grants, focusing on overdose prevention and treatment access. Additionally, the council discussed women's substance use disorder services and received a briefing on recent federal budget actions, including potential reductions and legislative updates regarding behavioral health funding.
Mar 18, 2026·BoardMeeting
Board
Drug Formulary Committee Meeting Minutes
The committee held a meeting to conduct organizational elections, review existing and new specialty drugs for continued prior authorization, and evaluate the 90-day supply drug list. Additionally, the committee performed a comprehensive review of the Preferred Drug List (PDL) across several therapeutic classes, including Alzheimer's agents, Angiotensin modulators, anticonvulsants, antiparkinson's agents, immunomodulators for atopic dermatitis, multiple sclerosis agents, and opiate dependence treatments, providing recommendations for additions, removals, or classification changes to the PDL.
Feb 2, 2026·BoardMeeting
Board
Behavioral Health Planning Council Meeting Minutes
The meeting covered several significant topics, including an update from the Behavioral Health Administration on program integrity, fraud prevention, and the recent Office of the Legislative Auditor audit. Participants reviewed block grant updates and future activities, discussed strategies for enhancing council engagement, and received a presentation on the Synar and Congratulate & Educate programs regarding tobacco retail compliance. Additionally, there was a briefing on federal funding, political priorities related to the reconciliation bill, and the appropriations timeline, alongside administrative updates regarding membership and per diem processes.
Extracted from official board minutes, strategic plans, and video transcripts.
